Moroccan fund UM6P has made an investment in South African outfit De Novo Diary which develops animal free diary products.
It produces milk proteins gained from the precision fermentation of yeast strains. This has in the past been difficult to achieve. They can then be used in a number of products to boost human nutrition.
Jean Louwrens, CEO of De Novo Dairy, said: “We are really excited to have the support of UM6P Ventures in this investment. They share our vision and mission to improve human nutrition while removing animals from the food. We will accelerate both R&D and scale-up efforts to achieve future milestones together.”
- BaaS on the rise
- FM61 boosts Morocco’s startup ecosystem
- ORA Tech raises US$1.5m
- Global fintech funding almost halves
- Global transaction value processed via soft POS to reach $11.8bn by 2028
UM6P is the investment arm of Mohammed VI Polytechnic University.
Ikram Labtaini, Scientific Development & Operations Lead, UM6P Ventures, added: “Dairy alternatives have gained global traction over the last few years due to the health-related and environmental benefits they present. We are pleased to add De Novo Dairy to our growing portfolio of Deeptech startups, work with their talented management team and support them while improving the African food system.”
No figures on the levels of investment made were given.
For more on the unbanked and underbanked.